Skip to main content
Signal8

Barber Daniel

SEC insider (Form 3/4/5 filer). CIK 0001742266. President and CEO at Aquestive Therapeutics, Inc. (AQST). 18 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in WARREN, NJ.

Companies Barber Daniel has filed insider reports for

  • Aquestive Therapeutics, Inc. (AQST): Director, Officer, President and CEO
Barber Daniel profile photo

Barber Daniel

CIK: 0001742266

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (55.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (27.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aquestive Therapeutics, Inc. logo
AQST

Aquestive Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Oct 15, 2026
    Sale
    Direct
    25K shares at avg. $4.22$106K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Sep 15, 2026
    Sale
    Direct
    25K shares at avg. $4.82$120K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Sep 8, 2026
    In-the-Money
    Direct
    91.7K shares at avg. $0.96$88K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Aug 17, 2026
    Sale
    Direct
    25K shares at avg. $4.29$107K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Jul 16, 2026
    Sale
    Direct
    20.4K shares at avg. $4.00$82K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Jul 15, 2026
    Sale
    Direct
    4.6K shares at avg. $4.03$19K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Jun 15, 2026
    Sale
    Direct
    25K shares at avg. $4.16$104K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    May 15, 2026
    Sale
    Direct
    8.3K shares at avg. $4.29$35K
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    May 5, 2026
    Tax Payment
    Direct
    335.9K shares at avg. $4.18$1.4M
  • Aquestive Therapeutics, Inc. logo
    AQST

    Aquestive Therapeutics, Inc.

    Mar 10, 2026
    Sale
    Direct
    180.7K shares at avg. $4.17$754K

1-10 of 18